LAKEN MEADOWS: Open Payments
NPI 1730841487 · DECATUR, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$417 in 24 payments from 14 companies in 2025. Trend: 2023 $380 · 2024 $400 · 2025 $417
Food & beverage: $417
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $70 |
| ABBVIE INC. | 3 | $53 |
| Astellas Pharma US Inc | 3 | $53 |
| Lilly USA, LLC | 2 | $41 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Dexcom, Inc. | 1 | $19 |
| PFIZER INC. | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
| Exact Sciences Corporation | 1 | $16 |
Products named: Veozah, Wegovy, MOUNJARO, CAPLYTA, VRAYLAR, Dexcom G6 Transmitter, SHINGRIX, ELIQUIS.
Industry payments across TX — which companies pay providers there.
